CliffBio

Xeris Pharmaceuticals

Patent cliffs & loss of exclusivity

A pharmaceutical company developing liquid-stable injectables

Company

AngelList URLhttps://angel.co/xeris-pharmaceuticals
Legal NameXeris Biopharma Holdings, Inc.
Company Operating StatusActive
Crunchbase URLhttps://www.crunchbase.com/organization/xeris-pharmaceuticals#section-overview
Facebook URLhttps://www.facebook.com/pg/xerispharmaceuticals/about/
Full Address180 N. Lasalle, Chicago, IL 60601, US
Instagram URLhttps://www.instagram.com/xerispharma/
LinkedIn URLhttps://www.linkedin.com/company/xeris-pharmaceuticals/

5 upcoming patent cliffs

DrugIngredientTypeCliff
  1. GVOKE HYPOPENGLUCAGONSmall mol.Apr 2036
  2. GVOKE HYPOPENGLUCAGONSmall mol.Apr 2036
  3. GVOKE KITGLUCAGONSmall mol.Apr 2036
  4. GVOKE PFSGLUCAGONSmall mol.Apr 2036
  5. GVOKE PFSGLUCAGONSmall mol.Apr 2036
  6. GVOKE VIALDXGLUCAGONSmall mol.—
  7. DARANIDEDICHLORPHENAMIDESmall mol.—
  8. KEVEYISDICHLORPHENAMIDESmall mol.—

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.

Xeris Pharmaceuticals — patent cliffs & loss of exclusivity | CliffBio